Competitive info

Prosecution History of Indian Patents

Ramesh Verma — Mon, 28 Jun 2010 05:02:53 +0000

Indian Patent Office has made available to the public the Prosecution History, Complete Specification and Examination Reports of published patent application and all details including e-Register in case of granted patents.

The URL is: http://ipindia.nic.in/ipirs1/patentsearch.htm

TCL launches new website – Human Touch of Chemistry

Ramesh Verma — Tue, 10 Nov 2009 15:30:28 +0000

Chemistry is going to be a lot more fun, as Tata Chemicals reaches out to Young India, through the launch of an interactive portal for the kids The Human Touch of Chemistry.

TCL has launched www.humantouchofchemistry.com at a formal function held at the Marriot, Mumbai to release the Dun & Bradstreet Publication ‘Indian Chemical Industry’.

Based on ‘Chemicals are Good, Chemistry is Fun’, Tata Chemicals have conceptualized a portal targeted at school students. The content has been specially selected to inculcate a love for chemistry and add on to the knowledge that students are already imparted through school curriculum. The website includes information spanning different topics including environmental issues like climate change, explanation of how chemicals react and why, naturally occurring chemical compounds, indispensible use of certain chemicals etc.

What’s the carbon footprint of your handwash?

Ramesh Verma — Sat, 25 Jul 2009 09:51:56 +0000

Reproduced from cnet news. Start-up Planet Metrics is developing software that could give consumers a better read on the embedded energy of everyday products.

The San Francisco-based company on Tuesday released the beta test version of its hosted application, which it calls Rapid Carbon Modeling. It also said Method, which makes eco-friendly home-cleaning products, is a customer.

There are a number of companies writing software for calculating how much energy is linked to a business’ operations and managing carbon emissions. Planet Metrics’ software is geared at manufacturers and makers of consumer packaged goods.

Using Planet Metrics’ software, a person could, for example, see how much energy consumption is associated with procuring the components that make up a cell phone. With that information, a company can then look for ways to cut energy consumption, such as reducing waste or finding another supplier.

Click here to read full

The Elephant in the Room

Ramesh Verma — Thu, 02 Jul 2009 14:43:22 +0000

Intellectual Asset Management has published the article “The Elephant in the Room” by Opperman, Craig P. The article focuses the skyrocketing cost and bloated patent portfolio of American Corporate, Low quality, Marginal relevance, and the process to overcome the same issue e.g. File far fewer applications, clean out that Junk and changing the culture of patenting the all.

Following is the excerpt cited from the article – Fundamentally, patents are assets. Their primary purpose is to protect the innovations underpinning company business. They should be able to function as barriers to entry, withstand competitor scrutiny and, if needs be, survive the rigours of a multimillion-dollar lawsuit. In theory, patents should be robust and valuable assets. In practice, however, the numbers suggest that today’s US patent portfolios, while not quite toxic, are performing poorly.

Click to read full

Abbott Loses Drug Patent Suit with Centocor

Ramesh Verma — Tue, 30 Jun 2009 14:33:01 +0000

Cited from NewYork Times. A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over rheumatoid arthritis drugs.

Abbott’s best-selling drug, Humira, competes with the drug Remicade, an arthritis treatment made by the Centocor unit of Johnson & Johnson. That company and New York University filed a federal patent infringement suit against Abbott in April 2007 in the Eastern District of Texas.

The product belongs to a class of drugs known as anti-TNF, which block tumor necrosis factor proteins in the blood. When present in excessive amounts, TNF can cause inflammation.

“We are particularly gratified that the jury recognized our valuable intellectual property, finding our patent both valid and infringed,” Kim Taylor, president of Centocor Ortho Biotech, said in a statement. Humira has been a major success for Abbott, which has been approved for uses psoriasis and Crohn’s disease. Abbott had $4.5 billion in Humira sales in 2008.

Click to Read full

Australia – Innovation Patent

Ramesh Verma — Mon, 22 Jun 2009 06:23:01 +0000

The Australia has a separate Patent protection apart from regular utility Patent termed “Innovation patent”, is a protection option specifically designed to protect inventions that do not meet the inventive threshold required for standard patents. Introduced in 2001 to stimulate innovation among small to medium business and local industry, the innovation patent is a relatively fast way to obtain protection for your new device, substance, method or process.

Innovation patents are intended to provide intellectual property rights for those incremental and lower level inventions that would not be sufficiently inventive to qualify for a standard patent. This is due to the inventive threshold being lowered compared to a standard patent, that is, the innovation patent requires an innovative step rather than an inventive step.

An innovation patent doesn’t allow you to legally stop others from copying your innovation unless you have your innovation patent examined. Examination of an innovation patent will only occur if requested by the patentee, a third party or the commissioner of patents. An innovation patent is only legally enforceable and certified if it has been examined by IP Australia and has met the requirements of the Patents Act.

Monsanto sues DuPont over patent

Ramesh Verma — Wed, 06 May 2009 13:55:46 +0000

The data is reproduced from the St. Louis Business Journal. Monsanto Co. has sued DuPont to prevent what it calls “unlawful use” of Monsanto’s herbicide-tolerant technologies in soybeans and corn.

DuPont subsidiary, Pioneer Hi-Bred International Inc., recently admitted that its technology “presents unacceptable risks to farmers,” Monsanto said.

In an effort to repair these deficiencies, Pioneer is “misusing” Monsanto’s Roundup Ready trait “to mask problems” with Pioneer’s technology, Monsanto said.

“As the saying goes, imitation is the sincerest form of flattery,” said Monsanto Chief Executive Officer Hugh Grant in a statement. “However, unlawfully taking technology is neither imitation nor flattery; it is unethical and wrong. A true technology company respects patents and its contractual agreements and delivers new products through its own innovation and honest collaboration. DuPont has failed on all counts.”

DuPont says Monsanto engages in “anti-competitive” conduct.

James Borel, DuPont group vice president, said the suit “incorrectly” claims that DuPont may not combine, or stack, its technology with any soybeans already containing Monsanto’s Roundup Ready trait.

In 2008, the U.S. Department of Justice required that Monsanto abandon similar “stacking” restrictions it imposed on its licensees producing Roundup Ready cottonseed as a condition to its acquisition of cotton seed company Delta & Pine Land, according to Borel.

“Monsanto has a long history of using litigation and aggressive tactics to preserve their monopoly and attempt to intimidate customers, seed partners and competitors,” he said in a statement.

Intellogist, New Patent Information Resource Tool

Ramesh Verma — Sat, 25 Apr 2009 04:13:43 +0000

Landon IP has launched a web page Intellogist, a free online tool that provides the intellectual property (IP) community with a revolutionary resource for finding objective information about patent searching tools and sharing best practices. Intellogist provides the informaton about

· Search System Reports: See detailed information on search systems

· Best Practices in Prior Art Searching: Collaborate on best practices for prior art searching

· Quick Table Comparisons: Quickly compare patent search systems

· Resource Finder: Find prior art resources by technical field

· Interactive Patent Coverage Map: Find patent search systems by clicking on a map

The website is also having the detailed comparison of database scope, features, and limitations of following patent search databases:

· Delphion

· EAST

· Esp@cenet

· FreePatentsOnline

· Google Patent Search

· MicroPatent PatentWeb

· PatAnalyst

· PatBase

· PatBase Express

· Patent Analysis Search System

· Patent Lens

· QPAT

· Qweb

· SumoBrain

· SureChem

· Surf-IP

· Thomson Innovation

· TotalPatent

· WIPS Global

India’s Traditional Knowledge Digital Library (TKDL): A powerful tool for patent examiners

Ramesh Verma — Mon, 20 Apr 2009 14:56:12 +0000

Data is reproduced from EPO website. On 2 February 2009 the Indian government granted access to its Traditional Knowledge Digital Library (TKDL), a unique database that houses the country’s traditional medical wisdom, to examiners at the European Patent Office (EPO).

EPO examiners will use the extensive database to prevent attempts at patenting existing traditional knowledge, a practice described as “bio-piracy”.

The co-operation between India and the EPO comes at a time when many countries are struggling to protect traditional and respected knowledge against exploitation, primarily in the pharmaceutical sector….

A unique encyclopaedia: The TKDL is the result of a US$ 2 million joint project between five Indian government organisations, including the Council of Scientific and Industrial Research (CSIR) and the National Institute of Science Communication and Informative Resources (NISCAIR).

Under the direction of Vinod Kumar Gupta, the head of NISCAIR, more than 150 experts in traditional medicine, law and computer science spent the past ten years arranging and classifying the TKDL.

Highlights of the vast database include:

§ 54 authoritative textbooks on ayurvedic medicine

§ Nearly 150,000 ayurvedic, unani and siddha medicines

§ Over 1,500 physical exercises and postures in yoga, more than 5,000 years old.

Click here to read full article.

IPVision Patent Analytics Tool

Ramesh Verma — Wed, 15 Apr 2009 11:40:28 +0000

The IPVision Patent Analytics provides the patent data mining and mapping tool (Find the Trees – See the Forest™) which enables to analyze patent portfolios, technologies and innovations, provide new competitive intelligence insights, enable companies to align intellectual property management with strategic objectives. The Map Analysis Features highlight important data on the map such as:

· Patent Cluster Maps™: show the patents grouped by the Selected Attribute- e.g., USTPO Class, By First Assignee, By First Named Inventor, or By Agent. This helps you investigate inventors, companies and technologies.

· Patent Family Maps™: show applications (provisional and non-provisional), continuations, continuations-in-part, divisionals, abandoned applications and related international filings.

· Visual Citation – Seminal Patents™: Which patents on the map are Seminal Patents – i.e., patents that have been cited by more than 20 other patents. In the Pro Version these patents are highlighted on the map.

· Litigation Analysis™: Which patents on the Map have changed ownership?

· Red Flag – Expired Patents Due to Non-Payment™: Highlighted patents have expired due to non-payment of USPTO maintenance fees, as per USPTO data.

· Orphan Analysis™: Highlighted patents by color group are Orphan Patents and Cluster Patents that have common inventors.

The sample analysis is available at link: Find the Trees – See the Forest™